Day One Biopharmaceuticals
Day One Biopharmaceutical, a start-up biotech company founded with a focus on developing therapies for children with cancer through drug repurposing announced its debut in
CAC2 Blog Team
May 21, 2020
Day One Biopharmaceutical, a start-up biotech company founded with a focus on developing therapies for children with cancer through drug repurposing announced its debut in
Everybody is worried these days. We have witnessed toilet paper hoarding and other behaviors that make us feel vulnerable and alone. That’s why we would
Our April CAC2 All-Member webinar hosted by Donna Ludwinski (Solving Kids Cancer) introduced Drs. Jeremy Schraw and Philip Lupo of Baylor College of Medicine who spoke about
Solving Kids’ Cancer and Max Cure Foundation offered a joint webinar: The Pandemic’s Impact on the Pediatric Cancer Research Landscape Timothy P. Cripe, Chief of
If you want to know what the $2.2 trillion CARES Act economic relief package means for nonprofits, donors, and individuals, have asked yourself “what can I
We are proud to share the #WhatCanIDo? Covid19 awareness graphic co-developed and promoted across the childhood cancer community by CAC2 members Be Strong, Fight On!,
CAC2 Members Greg Aune, Max Cure Foundation, and Solving Kids Cancer helped to bring answers to a community in turmoil over the Covid 19 crisis
The CAC2 Board presented the Spring All-Member webinar focusing on our 2019-2022 Strategic Plan and Leadership Planning, plus a variety of other CAC2-related topics. This
Our February CAC2 All-Member webinar focused on the role that tumor tissue can play in childhood cancer research efforts. Katie Gnatt from Alex’s Lemonade Stand Foundation
CAC2 Members Jack’s Angels, Dragon Master Foundation, Max Cure Foundation, Children’s Cancer Cause, and National Brain Tumor Society joined together with others in the community
